MD Anderson uses clinical trials to prevent, diagnose and treat cancer. Search for clinical trials here and also learn about the different phases.
Therapeutics Discovery scientists bring clinical cancer research to the lab and use unique model for drug development to benefit cancer patients.
After Evelyn Saunders Webb was diagnosed with non-small cell lung cancer, she learned it was driven by a rare mutation called EGFR exon 20 insertion. By testing a targeted therapy drug called poziotinib through a clinical trial, MD Anderson researchers seek to have a treatment option for more patients like her.
Michelle Hines didn't initially recognize the symptoms of breast cancer when she started experiencing them in the fall of 2014. But after a breast cancer diagnosis in June 2015, she participated in three different clinical trials at MD Anderson.
Results from an MD Anderson clinical trial indicate that a combination of immunotherapy and chemotherapy safely achieved a clinical response in most patients with newly diagnosed, advanced stage, high grade ovarian cancer.
Ferdinandos Skoulidis, M.D., Ph.D., remembers the exact moment he learned that sotorasib, a drug he’d tested for treatment of non-small cell lung cancer, had been approved by the Food and Drug Administration (FDA). It was the pinnacle of his career – and a life-changing moment for his patients.
Clinical Trials at MD Anderson - Search our database
When Primus Moore was told that amputation was the only option to treat kidney cancer that had spread to his bones, he came to MD Anderson for a second opinion. Thanks to an immunotherapy clinical trial and surgery, he’s back in action and still has his leg.
An immunotherapy used to treat advanced lung cancer is tested in a clinical trial to prevent the disease by eradicating precancerous growths.
SPOT-ON) approach for dyspnea treatment in cancer patients: an R01 randomized clinical trial MD Anderson Study Status Enrolling Treatment Agent Description To...